Drug Shortage Report for FULPHILA
Report ID | 176254 |
Drug Identification Number | 02484153 |
Brand name | FULPHILA |
Common or Proper name | Pegfilgrastim |
Company Name | BIOSIMILAR COLLABORATIONS IRELAND LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | PEGFILGRASTIM |
Strength(s) | 10MG |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS |
Packaging size | single dose syringe containing 6mg pegfilgrastim in 0.6mL (10mg/mL) |
ATC code | L03AA |
ATC description | IMMUNOSTIMULANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2022-12-07 |
Actual start date | 2022-12-12 |
Estimated end date | 2023-03-14 |
Actual end date | 2023-03-30 |
Shortage status | Resolved |
Updated date | 2023-04-20 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | GRANGE PARADE, BALDOYLE INDUSTRIAL ESTATE, DUBLIN 13 DUBLIN, -- IRELAND D13R20R |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v15 | 2023-04-20 | French | Compare |
v14 | 2023-04-20 | English | Compare |
v13 | 2023-02-01 | French | Compare |
v12 | 2023-02-01 | English | Compare |
v11 | 2023-01-17 | French | Compare |
v10 | 2023-01-17 | English | Compare |
v9 | 2023-01-10 | French | Compare |
v8 | 2023-01-10 | English | Compare |
v7 | 2022-12-19 | French | Compare |
v6 | 2022-12-19 | English | Compare |
v5 | 2022-12-08 | French | Compare |
v4 | 2022-12-08 | English | Compare |
v3 | 2022-12-08 | English | Compare |
v2 | 2022-11-29 | French | Compare |
v1 | 2022-11-29 | English | Compare |
Showing 1 to 15 of 15